| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetic Testing | 88 | 2023 | 3443 | 7.570 |
Why?
|
| Genetic Variation | 80 | 2023 | 6546 | 5.370 |
Why?
|
| Genome, Human | 66 | 2023 | 4420 | 5.150 |
Why?
|
| Genomics | 82 | 2023 | 5722 | 4.650 |
Why?
|
| Databases, Genetic | 42 | 2023 | 1782 | 4.520 |
Why?
|
| Genetics, Medical | 22 | 2022 | 338 | 3.660 |
Why?
|
| Information Dissemination | 22 | 2023 | 1100 | 3.460 |
Why?
|
| Genetic Diseases, Inborn | 12 | 2020 | 587 | 3.110 |
Why?
|
| Rare Diseases | 13 | 2023 | 553 | 2.940 |
Why?
|
| Sequence Analysis, DNA | 36 | 2022 | 4803 | 2.520 |
Why?
|
| High-Throughput Nucleotide Sequencing | 32 | 2024 | 3598 | 1.990 |
Why?
|
| Genetic Predisposition to Disease | 48 | 2024 | 17449 | 1.860 |
Why?
|
| Hearing Loss | 20 | 2022 | 765 | 1.770 |
Why?
|
| Laboratories | 8 | 2024 | 463 | 1.680 |
Why?
|
| Pathology, Molecular | 5 | 2021 | 326 | 1.530 |
Why?
|
| Hearing Loss, Sensorineural | 13 | 2019 | 770 | 1.420 |
Why?
|
| Connexins | 15 | 2019 | 360 | 1.410 |
Why?
|
| Genetic Association Studies | 17 | 2022 | 2702 | 1.230 |
Why?
|
| Molecular Diagnostic Techniques | 6 | 2021 | 602 | 1.130 |
Why?
|
| Genetic Counseling | 13 | 2022 | 600 | 0.980 |
Why?
|
| Neonatal Screening | 10 | 2023 | 591 | 0.950 |
Why?
|
| Software | 23 | 2023 | 4442 | 0.930 |
Why?
|
| Cardiomyopathy, Hypertrophic | 8 | 2017 | 1265 | 0.900 |
Why?
|
| Disease | 8 | 2023 | 681 | 0.860 |
Why?
|
| Computational Biology | 14 | 2023 | 3523 | 0.830 |
Why?
|
| Deafness | 9 | 2022 | 461 | 0.790 |
Why?
|
| Mutation | 41 | 2023 | 29784 | 0.790 |
Why?
|
| Humans | 246 | 2024 | 744220 | 0.710 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2015 | 3921 | 0.700 |
Why?
|
| Guidelines as Topic | 5 | 2019 | 1404 | 0.700 |
Why?
|
| Cardiomyopathies | 6 | 2019 | 1913 | 0.690 |
Why?
|
| Phenotype | 38 | 2024 | 16365 | 0.690 |
Why?
|
| Pharmacogenetics | 7 | 2022 | 676 | 0.660 |
Why?
|
| Incidental Findings | 8 | 2018 | 689 | 0.660 |
Why?
|
| Awards and Prizes | 1 | 2023 | 375 | 0.640 |
Why?
|
| Gene Frequency | 16 | 2024 | 3588 | 0.620 |
Why?
|
| Cardiomyopathy, Dilated | 9 | 2023 | 851 | 0.600 |
Why?
|
| Alleles | 19 | 2023 | 6938 | 0.590 |
Why?
|
| Publications | 2 | 2020 | 195 | 0.560 |
Why?
|
| Metagenomics | 1 | 2019 | 430 | 0.550 |
Why?
|
| Clinical Laboratory Information Systems | 1 | 2017 | 108 | 0.550 |
Why?
|
| Usher Syndromes | 5 | 2018 | 50 | 0.540 |
Why?
|
| Delivery of Health Care | 6 | 2023 | 5319 | 0.520 |
Why?
|
| Blindness | 4 | 2012 | 617 | 0.500 |
Why?
|
| Professional Role | 1 | 2018 | 306 | 0.500 |
Why?
|
| Genes, Recessive | 9 | 2024 | 643 | 0.500 |
Why?
|
| DNA Mutational Analysis | 12 | 2013 | 4188 | 0.490 |
Why?
|
| Data Interpretation, Statistical | 3 | 2019 | 2715 | 0.490 |
Why?
|
| Penetrance | 6 | 2023 | 381 | 0.490 |
Why?
|
| Long QT Syndrome | 4 | 2022 | 453 | 0.470 |
Why?
|
| Multifactorial Inheritance | 5 | 2023 | 1194 | 0.460 |
Why?
|
| Medical Informatics | 5 | 2021 | 743 | 0.450 |
Why?
|
| Information Storage and Retrieval | 1 | 2018 | 824 | 0.440 |
Why?
|
| Myosins | 4 | 2021 | 409 | 0.440 |
Why?
|
| Duty to Recontact | 3 | 2021 | 20 | 0.430 |
Why?
|
| Clinical Laboratory Techniques | 2 | 2017 | 738 | 0.420 |
Why?
|
| Pedigree | 15 | 2021 | 4648 | 0.420 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2023 | 1695 | 0.410 |
Why?
|
| Nephrotic Syndrome | 3 | 2021 | 389 | 0.400 |
Why?
|
| DNA Copy Number Variations | 6 | 2021 | 1940 | 0.400 |
Why?
|
| Heterozygote | 12 | 2023 | 2805 | 0.390 |
Why?
|
| Terminology as Topic | 4 | 2020 | 1548 | 0.360 |
Why?
|
| Genome | 5 | 2022 | 1808 | 0.360 |
Why?
|
| Sequence Analysis | 4 | 2020 | 256 | 0.350 |
Why?
|
| Patient Selection | 2 | 2018 | 4216 | 0.340 |
Why?
|
| Genotype | 19 | 2024 | 12956 | 0.340 |
Why?
|
| Adenosine Monophosphate | 3 | 2021 | 275 | 0.330 |
Why?
|
| Evidence-Based Practice | 3 | 2019 | 500 | 0.330 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2018 | 2041 | 0.320 |
Why?
|
| Spasms, Infantile | 1 | 2012 | 305 | 0.320 |
Why?
|
| Donor Selection | 1 | 2009 | 201 | 0.310 |
Why?
|
| Access to Information | 3 | 2023 | 320 | 0.300 |
Why?
|
| Polymerase Chain Reaction | 6 | 2018 | 6172 | 0.300 |
Why?
|
| United States | 31 | 2024 | 69867 | 0.300 |
Why?
|
| Antigens, Human Platelet | 2 | 2018 | 43 | 0.290 |
Why?
|
| Biological Specimen Banks | 2 | 2023 | 712 | 0.290 |
Why?
|
| Podocytes | 3 | 2021 | 396 | 0.290 |
Why?
|
| Nephrology | 2 | 2020 | 263 | 0.290 |
Why?
|
| Urogenital Abnormalities | 2 | 2020 | 261 | 0.280 |
Why?
|
| Disclosure | 5 | 2021 | 736 | 0.280 |
Why?
|
| Genetics, Population | 2 | 2023 | 934 | 0.280 |
Why?
|
| Infant, Newborn | 22 | 2023 | 25618 | 0.270 |
Why?
|
| Biomedical Research | 3 | 2016 | 3311 | 0.270 |
Why?
|
| Societies, Medical | 6 | 2019 | 3741 | 0.270 |
Why?
|
| Chromosome Mapping | 8 | 2023 | 4742 | 0.270 |
Why?
|
| Cochlear Diseases | 1 | 2005 | 23 | 0.260 |
Why?
|
| Primary Health Care | 6 | 2023 | 4556 | 0.260 |
Why?
|
| Genome-Wide Association Study | 11 | 2024 | 12264 | 0.260 |
Why?
|
| Carrier Proteins | 6 | 2021 | 5021 | 0.260 |
Why?
|
| Spermatozoa | 1 | 2009 | 625 | 0.260 |
Why?
|
| Genes, BRCA2 | 2 | 2019 | 618 | 0.260 |
Why?
|
| Speech Intelligibility | 1 | 2005 | 81 | 0.250 |
Why?
|
| Kidney Diseases | 2 | 2020 | 2147 | 0.250 |
Why?
|
| Mutation, Missense | 5 | 2019 | 2563 | 0.250 |
Why?
|
| Point Mutation | 1 | 2010 | 1624 | 0.250 |
Why?
|
| Genes, Dominant | 3 | 2016 | 880 | 0.240 |
Why?
|
| Membrane Proteins | 8 | 2019 | 7879 | 0.240 |
Why?
|
| Genetic Heterogeneity | 2 | 2019 | 733 | 0.230 |
Why?
|
| Child | 33 | 2024 | 77679 | 0.230 |
Why?
|
| Sequence Deletion | 3 | 2015 | 1526 | 0.230 |
Why?
|
| Base Sequence | 10 | 2023 | 12801 | 0.230 |
Why?
|
| Virulence | 3 | 2024 | 1333 | 0.230 |
Why?
|
| Developmental Disabilities | 3 | 2021 | 1456 | 0.230 |
Why?
|
| Child, Preschool | 21 | 2021 | 40992 | 0.220 |
Why?
|
| Cochlea | 4 | 2011 | 829 | 0.220 |
Why?
|
| Female | 68 | 2023 | 380197 | 0.220 |
Why?
|
| Databases, Nucleic Acid | 2 | 2016 | 211 | 0.210 |
Why?
|
| Research Report | 2 | 2016 | 355 | 0.210 |
Why?
|
| Male | 62 | 2022 | 350027 | 0.210 |
Why?
|
| Shal Potassium Channels | 1 | 2021 | 21 | 0.210 |
Why?
|
| Human Genome Project | 3 | 2020 | 192 | 0.210 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2021 | 1541 | 0.210 |
Why?
|
| Database Management Systems | 2 | 2015 | 270 | 0.210 |
Why?
|
| Practice Guidelines as Topic | 6 | 2020 | 7281 | 0.200 |
Why?
|
| Infant | 20 | 2021 | 35129 | 0.200 |
Why?
|
| Nervous System Diseases | 1 | 2012 | 1623 | 0.200 |
Why?
|
| Truth Disclosure | 2 | 2019 | 436 | 0.200 |
Why?
|
| Genome, Mitochondrial | 1 | 2022 | 71 | 0.200 |
Why?
|
| Hereditary Central Nervous System Demyelinating Diseases | 1 | 2021 | 39 | 0.200 |
Why?
|
| Tandem Repeat Sequences | 1 | 2022 | 185 | 0.200 |
Why?
|
| Research Personnel | 2 | 2017 | 573 | 0.200 |
Why?
|
| Intranuclear Space | 1 | 2021 | 15 | 0.200 |
Why?
|
| Inheritance Patterns | 1 | 2023 | 340 | 0.200 |
Why?
|
| Algorithms | 7 | 2019 | 13885 | 0.190 |
Why?
|
| Electronic Health Records | 7 | 2023 | 4463 | 0.190 |
Why?
|
| Reproducibility of Results | 11 | 2021 | 19907 | 0.190 |
Why?
|
| Uncertainty | 3 | 2023 | 734 | 0.190 |
Why?
|
| Endophenotypes | 1 | 2022 | 250 | 0.190 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2021 | 298 | 0.190 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 2020 | 105 | 0.190 |
Why?
|
| Consensus | 2 | 2020 | 2958 | 0.190 |
Why?
|
| Primates | 1 | 2023 | 544 | 0.190 |
Why?
|
| Gastritis | 1 | 2022 | 196 | 0.180 |
Why?
|
| Adult | 41 | 2024 | 214035 | 0.180 |
Why?
|
| Spliceosomes | 1 | 2020 | 110 | 0.180 |
Why?
|
| Middle East | 1 | 2020 | 219 | 0.180 |
Why?
|
| Neoplasms | 5 | 2021 | 21672 | 0.180 |
Why?
|
| Informed Consent | 4 | 2021 | 995 | 0.180 |
Why?
|
| Tissue Donors | 1 | 2009 | 2242 | 0.180 |
Why?
|
| Anemia, Aplastic | 1 | 2022 | 226 | 0.180 |
Why?
|
| North America | 1 | 2023 | 1250 | 0.180 |
Why?
|
| Urinary Tract | 2 | 2020 | 308 | 0.180 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2021 | 129 | 0.180 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2022 | 241 | 0.180 |
Why?
|
| Cadherins | 2 | 2016 | 907 | 0.170 |
Why?
|
| American Medical Association | 1 | 2019 | 65 | 0.170 |
Why?
|
| Ion Channel Gating | 1 | 2021 | 437 | 0.170 |
Why?
|
| Duty to Warn | 1 | 2019 | 30 | 0.170 |
Why?
|
| Transport Vesicles | 1 | 2019 | 83 | 0.170 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2021 | 437 | 0.170 |
Why?
|
| Preimplantation Diagnosis | 1 | 2021 | 151 | 0.170 |
Why?
|
| Medical History Taking | 3 | 2020 | 783 | 0.170 |
Why?
|
| Pregnancy Trimester, First | 2 | 2023 | 853 | 0.170 |
Why?
|
| Ear | 1 | 1999 | 173 | 0.170 |
Why?
|
| Biotinidase | 1 | 2018 | 19 | 0.170 |
Why?
|
| Arabs | 1 | 2020 | 178 | 0.170 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2018 | 849 | 0.170 |
Why?
|
| Gene Dosage | 5 | 2023 | 1251 | 0.170 |
Why?
|
| rab5 GTP-Binding Proteins | 1 | 2018 | 50 | 0.160 |
Why?
|
| Cerebellar Diseases | 1 | 2020 | 222 | 0.160 |
Why?
|
| Esophageal Atresia | 1 | 2021 | 201 | 0.160 |
Why?
|
| Nerve Tissue Proteins | 2 | 2021 | 4465 | 0.160 |
Why?
|
| Genetic Loci | 2 | 2019 | 2575 | 0.160 |
Why?
|
| Rh-Hr Blood-Group System | 1 | 2018 | 65 | 0.160 |
Why?
|
| DNA | 6 | 2021 | 7303 | 0.160 |
Why?
|
| Genomic Library | 2 | 2016 | 193 | 0.160 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 2018 | 106 | 0.160 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2019 | 246 | 0.160 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2023 | 373 | 0.160 |
Why?
|
| Adolescent | 22 | 2022 | 85759 | 0.150 |
Why?
|
| Retinal Degeneration | 2 | 2012 | 415 | 0.150 |
Why?
|
| Semicircular Canals | 2 | 2016 | 198 | 0.150 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2021 | 359 | 0.150 |
Why?
|
| Polymorphism, Single Nucleotide | 9 | 2023 | 15525 | 0.150 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2021 | 379 | 0.150 |
Why?
|
| Vesicular Transport Proteins | 1 | 2019 | 377 | 0.140 |
Why?
|
| DNA, Mitochondrial | 1 | 2022 | 817 | 0.140 |
Why?
|
| False Positive Reactions | 2 | 2016 | 981 | 0.140 |
Why?
|
| Age of Onset | 3 | 2019 | 3270 | 0.140 |
Why?
|
| Microcephaly | 1 | 2020 | 432 | 0.140 |
Why?
|
| Blood Vessels | 1 | 2002 | 1126 | 0.140 |
Why?
|
| Homozygote | 5 | 2013 | 1786 | 0.140 |
Why?
|
| Ion Channels | 3 | 2013 | 1056 | 0.140 |
Why?
|
| Gene Rearrangement | 1 | 2021 | 1179 | 0.140 |
Why?
|
| ABO Blood-Group System | 1 | 2018 | 367 | 0.130 |
Why?
|
| Cardiovascular Diseases | 7 | 2023 | 15161 | 0.130 |
Why?
|
| Young Adult | 14 | 2021 | 56436 | 0.130 |
Why?
|
| Health | 1 | 2019 | 394 | 0.130 |
Why?
|
| National Library of Medicine (U.S.) | 1 | 2015 | 35 | 0.130 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2017 | 161 | 0.130 |
Why?
|
| Electrocardiography | 3 | 2022 | 6442 | 0.130 |
Why?
|
| Sensitivity and Specificity | 7 | 2019 | 14726 | 0.130 |
Why?
|
| Family | 4 | 2020 | 3148 | 0.130 |
Why?
|
| Case-Control Studies | 8 | 2020 | 21752 | 0.130 |
Why?
|
| Epilepsy | 3 | 2021 | 3310 | 0.130 |
Why?
|
| Embryo, Mammalian | 1 | 2021 | 1701 | 0.130 |
Why?
|
| Ear Diseases | 1 | 2016 | 170 | 0.130 |
Why?
|
| Pancreatitis | 1 | 2022 | 1091 | 0.130 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2016 | 168 | 0.130 |
Why?
|
| Parents | 2 | 2019 | 3407 | 0.130 |
Why?
|
| Research Subjects | 2 | 2019 | 239 | 0.130 |
Why?
|
| Genes, BRCA1 | 1 | 2018 | 781 | 0.130 |
Why?
|
| Calcium-Binding Proteins | 1 | 2019 | 1080 | 0.120 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2018 | 427 | 0.120 |
Why?
|
| Colonic Polyps | 1 | 2019 | 542 | 0.120 |
Why?
|
| Retina | 5 | 2011 | 2616 | 0.120 |
Why?
|
| Blood Group Antigens | 1 | 2015 | 180 | 0.120 |
Why?
|
| Mechanotransduction, Cellular | 2 | 2013 | 541 | 0.120 |
Why?
|
| Communication | 3 | 2024 | 3749 | 0.120 |
Why?
|
| Peripheral Vascular Diseases | 1 | 1997 | 550 | 0.110 |
Why?
|
| Fertilization in Vitro | 1 | 2021 | 1284 | 0.110 |
Why?
|
| Models, Genetic | 1 | 2023 | 3494 | 0.110 |
Why?
|
| Audiometry, Pure-Tone | 2 | 2005 | 204 | 0.110 |
Why?
|
| Carbidopa | 1 | 2012 | 31 | 0.110 |
Why?
|
| Sample Size | 1 | 2016 | 846 | 0.110 |
Why?
|
| Patient Access to Records | 1 | 2014 | 118 | 0.110 |
Why?
|
| Societies, Scientific | 1 | 2014 | 220 | 0.110 |
Why?
|
| Forkhead Transcription Factors | 1 | 2020 | 1613 | 0.110 |
Why?
|
| Retinitis Pigmentosa | 2 | 2011 | 386 | 0.110 |
Why?
|
| Sarcomeres | 2 | 2012 | 374 | 0.110 |
Why?
|
| Patients | 2 | 2018 | 900 | 0.110 |
Why?
|
| Outpatients | 1 | 2020 | 1486 | 0.110 |
Why?
|
| Exons | 4 | 2023 | 2439 | 0.110 |
Why?
|
| Databases, Factual | 5 | 2022 | 7730 | 0.110 |
Why?
|
| Arthrogryposis | 1 | 2013 | 72 | 0.110 |
Why?
|
| Auditory Threshold | 2 | 2005 | 366 | 0.100 |
Why?
|
| Levodopa | 1 | 2012 | 219 | 0.100 |
Why?
|
| Hearing Loss, Bilateral | 1 | 2011 | 54 | 0.100 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2022 | 1423 | 0.100 |
Why?
|
| Audiometry | 2 | 2010 | 243 | 0.100 |
Why?
|
| Mucin-1 | 1 | 2016 | 544 | 0.100 |
Why?
|
| Cohort Studies | 10 | 2021 | 40559 | 0.100 |
Why?
|
| Hearing Loss, Mixed Conductive-Sensorineural | 1 | 2011 | 13 | 0.100 |
Why?
|
| Genes, Synthetic | 1 | 2011 | 90 | 0.100 |
Why?
|
| Expert Systems | 1 | 2011 | 81 | 0.100 |
Why?
|
| Aged, 80 and over | 8 | 2019 | 57768 | 0.100 |
Why?
|
| Peer Review, Research | 1 | 2014 | 329 | 0.100 |
Why?
|
| Knowledge Bases | 1 | 2011 | 85 | 0.100 |
Why?
|
| Intellectual Property | 1 | 2010 | 31 | 0.090 |
Why?
|
| International Cooperation | 1 | 2017 | 1421 | 0.090 |
Why?
|
| Insemination, Artificial, Heterologous | 1 | 2009 | 10 | 0.090 |
Why?
|
| Sperm Banks | 1 | 2009 | 7 | 0.090 |
Why?
|
| Validation Studies as Topic | 1 | 2010 | 159 | 0.090 |
Why?
|
| Research Design | 3 | 2014 | 5987 | 0.090 |
Why?
|
| Prenatal Diagnosis | 1 | 2017 | 1236 | 0.090 |
Why?
|
| Base Composition | 1 | 2010 | 293 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2019 | 9960 | 0.090 |
Why?
|
| Middle Aged | 20 | 2021 | 213367 | 0.090 |
Why?
|
| Periodicals as Topic | 1 | 2020 | 1432 | 0.090 |
Why?
|
| Cardiac Myosins | 1 | 2009 | 117 | 0.090 |
Why?
|
| Vestibule, Labyrinth | 1 | 2011 | 235 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2020 | 3023 | 0.080 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 3461 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 2 | 2021 | 5396 | 0.080 |
Why?
|
| Costs and Cost Analysis | 1 | 2015 | 1682 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2024 | 9147 | 0.080 |
Why?
|
| Thrombophilia | 1 | 2011 | 305 | 0.080 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 2204 | 0.080 |
Why?
|
| Genetic Research | 2 | 2021 | 174 | 0.080 |
Why?
|
| Syndrome | 4 | 2021 | 3250 | 0.080 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2012 | 372 | 0.080 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 1504 | 0.080 |
Why?
|
| Pilot Projects | 5 | 2020 | 8321 | 0.080 |
Why?
|
| Heart Diseases | 1 | 2021 | 2790 | 0.080 |
Why?
|
| Physicians | 2 | 2017 | 4564 | 0.080 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2013 | 615 | 0.080 |
Why?
|
| Myosin Heavy Chains | 1 | 2009 | 414 | 0.080 |
Why?
|
| Prospective Studies | 6 | 2023 | 53280 | 0.080 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2009 | 1375 | 0.080 |
Why?
|
| Aged | 13 | 2019 | 163253 | 0.080 |
Why?
|
| Drug Discovery | 1 | 2015 | 1058 | 0.070 |
Why?
|
| Visual Fields | 2 | 2011 | 1049 | 0.070 |
Why?
|
| Pregnancy | 5 | 2023 | 29142 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 3646 | 0.070 |
Why?
|
| Chromosome Breakpoints | 2 | 2018 | 98 | 0.070 |
Why?
|
| Receptors, Cholinergic | 2 | 1991 | 238 | 0.070 |
Why?
|
| Internet | 2 | 2022 | 3063 | 0.070 |
Why?
|
| Temporal Bone | 1 | 2011 | 661 | 0.070 |
Why?
|
| DNA-Binding Proteins | 2 | 2021 | 9647 | 0.070 |
Why?
|
| X Chromosome | 2 | 2002 | 815 | 0.070 |
Why?
|
| Haplotypes | 3 | 2022 | 2781 | 0.070 |
Why?
|
| DNA Primers | 2 | 2014 | 2892 | 0.070 |
Why?
|
| Ultrasonography | 1 | 2019 | 5982 | 0.070 |
Why?
|
| National Human Genome Research Institute (U.S.) | 2 | 2016 | 23 | 0.070 |
Why?
|
| RNA, Messenger | 4 | 2018 | 13036 | 0.070 |
Why?
|
| Cross-Sectional Studies | 4 | 2023 | 25043 | 0.060 |
Why?
|
| Cardiomegaly | 1 | 2008 | 620 | 0.060 |
Why?
|
| Fee-for-Service Plans | 1 | 2010 | 694 | 0.060 |
Why?
|
| Disease Susceptibility | 2 | 2022 | 1782 | 0.060 |
Why?
|
| Risk Assessment | 6 | 2018 | 23337 | 0.060 |
Why?
|
| Amino Acid Substitution | 2 | 2021 | 1792 | 0.060 |
Why?
|
| RNA Splicing | 2 | 2021 | 907 | 0.060 |
Why?
|
| Molecular Sequence Data | 6 | 2013 | 18116 | 0.060 |
Why?
|
| Kidney | 4 | 2021 | 7183 | 0.060 |
Why?
|
| Attitude of Health Personnel | 2 | 2015 | 3842 | 0.060 |
Why?
|
| Animals | 17 | 2023 | 168788 | 0.060 |
Why?
|
| Vision Disorders | 1 | 2011 | 1059 | 0.060 |
Why?
|
| Population Groups | 2 | 2016 | 209 | 0.060 |
Why?
|
| Transcription Factors | 2 | 2021 | 12207 | 0.060 |
Why?
|
| Research | 3 | 2018 | 1999 | 0.060 |
Why?
|
| Medical Oncology | 1 | 2015 | 2265 | 0.060 |
Why?
|
| Public Health | 1 | 2017 | 2603 | 0.060 |
Why?
|
| Vertebrates | 1 | 2004 | 227 | 0.060 |
Why?
|
| Disease Progression | 3 | 2018 | 13280 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2018 | 1676 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 3509 | 0.060 |
Why?
|
| Hearing Disorders | 1 | 2003 | 125 | 0.060 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 6489 | 0.060 |
Why?
|
| Risk Factors | 8 | 2024 | 72280 | 0.050 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2012 | 1162 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2005 | 473 | 0.050 |
Why?
|
| Healthcare Disparities | 1 | 2018 | 3158 | 0.050 |
Why?
|
| Retinal Diseases | 1 | 2008 | 683 | 0.050 |
Why?
|
| Stria Vascularis | 1 | 2002 | 31 | 0.050 |
Why?
|
| Retinal Dystrophies | 1 | 2023 | 58 | 0.050 |
Why?
|
| Founder Effect | 1 | 2023 | 190 | 0.050 |
Why?
|
| Genetic Techniques | 1 | 2005 | 435 | 0.050 |
Why?
|
| Prevalence | 4 | 2023 | 15226 | 0.050 |
Why?
|
| RNA, Small Interfering | 3 | 2019 | 3505 | 0.050 |
Why?
|
| Vestibular Function Tests | 1 | 2002 | 127 | 0.050 |
Why?
|
| Quality Assurance, Health Care | 1 | 2012 | 2211 | 0.050 |
Why?
|
| Acetonitriles | 1 | 2022 | 53 | 0.050 |
Why?
|
| Hair Cells, Auditory | 1 | 2004 | 361 | 0.050 |
Why?
|
| Hemizygote | 1 | 2021 | 28 | 0.050 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2022 | 117 | 0.050 |
Why?
|
| Asymptomatic Diseases | 2 | 2017 | 552 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 2 | 2017 | 234 | 0.050 |
Why?
|
| Finland | 1 | 2023 | 602 | 0.050 |
Why?
|
| Health Level Seven | 1 | 2021 | 38 | 0.050 |
Why?
|
| Workflow | 2 | 2016 | 847 | 0.050 |
Why?
|
| Germ-Line Mutation | 2 | 2022 | 1787 | 0.050 |
Why?
|
| Chromosomes, Human | 1 | 2003 | 457 | 0.050 |
Why?
|
| Laboratory Proficiency Testing | 1 | 2020 | 19 | 0.050 |
Why?
|
| Heredodegenerative Disorders, Nervous System | 1 | 2020 | 17 | 0.050 |
Why?
|
| Genes, X-Linked | 1 | 2021 | 128 | 0.050 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2002 | 250 | 0.050 |
Why?
|
| HEK293 Cells | 2 | 2020 | 4201 | 0.050 |
Why?
|
| Amphibian Proteins | 1 | 2020 | 36 | 0.050 |
Why?
|
| Hearing | 1 | 2004 | 482 | 0.050 |
Why?
|
| Health Services Accessibility | 1 | 2018 | 5138 | 0.050 |
Why?
|
| STAT1 Transcription Factor | 1 | 2022 | 320 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2005 | 1677 | 0.050 |
Why?
|
| Health Care Costs | 3 | 2018 | 3209 | 0.050 |
Why?
|
| Molecular Sequence Annotation | 1 | 2023 | 528 | 0.050 |
Why?
|
| Receptors, Interleukin | 1 | 2021 | 245 | 0.050 |
Why?
|
| Xenopus | 2 | 2020 | 712 | 0.050 |
Why?
|
| Computer-Assisted Instruction | 1 | 2003 | 365 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 12075 | 0.040 |
Why?
|
| Drosophila melanogaster | 2 | 2019 | 1708 | 0.040 |
Why?
|
| Codon, Nonsense | 1 | 2021 | 281 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 6773 | 0.040 |
Why?
|
| Data Collection | 2 | 2023 | 3340 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2012 | 6991 | 0.040 |
Why?
|
| Receptors, Nicotinic | 1 | 1982 | 497 | 0.040 |
Why?
|
| Ribonuclease III | 1 | 2021 | 275 | 0.040 |
Why?
|
| Jews | 1 | 2021 | 385 | 0.040 |
Why?
|
| Open Reading Frames | 1 | 2022 | 810 | 0.040 |
Why?
|
| Canada | 2 | 2019 | 2065 | 0.040 |
Why?
|
| Selection, Genetic | 1 | 2023 | 914 | 0.040 |
Why?
|
| Larva | 1 | 2020 | 519 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2022 | 794 | 0.040 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2021 | 434 | 0.040 |
Why?
|
| Eye Proteins | 1 | 2002 | 646 | 0.040 |
Why?
|
| Reproduction | 1 | 2023 | 668 | 0.040 |
Why?
|
| Linkage Disequilibrium | 2 | 2013 | 1997 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 2019 | 898 | 0.040 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2021 | 375 | 0.040 |
Why?
|
| Zebrafish Proteins | 1 | 2004 | 1004 | 0.040 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2018 | 70 | 0.040 |
Why?
|
| Visual Field Tests | 2 | 2011 | 383 | 0.040 |
Why?
|
| Protein Subunits | 1 | 2021 | 960 | 0.040 |
Why?
|
| Exocytosis | 1 | 2019 | 353 | 0.040 |
Why?
|
| Cell Line | 4 | 2021 | 15999 | 0.040 |
Why?
|
| Acoustic Stimulation | 1 | 2002 | 1217 | 0.040 |
Why?
|
| Licensure | 1 | 2018 | 124 | 0.040 |
Why?
|
| Liability, Legal | 1 | 2019 | 213 | 0.040 |
Why?
|
| Mice | 6 | 2021 | 81178 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2020 | 809 | 0.040 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 15070 | 0.040 |
Why?
|
| Erythrocytes | 2 | 2018 | 2454 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 2020 | 1246 | 0.040 |
Why?
|
| Ethics, Research | 1 | 2019 | 191 | 0.040 |
Why?
|
| Genes | 2 | 2014 | 1893 | 0.040 |
Why?
|
| Saudi Arabia | 1 | 2017 | 209 | 0.040 |
Why?
|
| Costa Rica | 1 | 1997 | 177 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2003 | 2634 | 0.040 |
Why?
|
| Genomic Structural Variation | 1 | 2017 | 65 | 0.040 |
Why?
|
| Cataract | 1 | 2023 | 834 | 0.040 |
Why?
|
| Gene Deletion | 2 | 2015 | 2751 | 0.040 |
Why?
|
| Infertility, Female | 1 | 2023 | 787 | 0.040 |
Why?
|
| Personal Autonomy | 1 | 2019 | 298 | 0.030 |
Why?
|
| Gene Duplication | 1 | 2017 | 330 | 0.030 |
Why?
|
| Borrelia burgdorferi Group | 1 | 1996 | 97 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 2019 | 881 | 0.030 |
Why?
|
| Information Services | 1 | 2017 | 244 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2020 | 14556 | 0.030 |
Why?
|
| Patient Preference | 2 | 2013 | 887 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 5853 | 0.030 |
Why?
|
| Intention | 1 | 2018 | 341 | 0.030 |
Why?
|
| Australia | 1 | 2019 | 1169 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 1 | 2024 | 2763 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2019 | 627 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2023 | 2309 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 2021 | 1364 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 1999 | 690 | 0.030 |
Why?
|
| Pyrroles | 1 | 2022 | 1143 | 0.030 |
Why?
|
| Introns | 1 | 2018 | 991 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2019 | 780 | 0.030 |
Why?
|
| Breast Neoplasms | 3 | 2019 | 20817 | 0.030 |
Why?
|
| Probability | 1 | 2020 | 2505 | 0.030 |
Why?
|
| Karyotyping | 1 | 1997 | 1243 | 0.030 |
Why?
|
| Dogs | 1 | 2019 | 3913 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2023 | 2682 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2021 | 1836 | 0.030 |
Why?
|
| Family Health | 1 | 1999 | 1282 | 0.030 |
Why?
|
| Vinculin | 1 | 2014 | 62 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 1917 | 0.030 |
Why?
|
| United Arab Emirates | 1 | 2013 | 42 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 4752 | 0.030 |
Why?
|
| Ambulatory Care Facilities | 1 | 2020 | 933 | 0.030 |
Why?
|
| Desmoplakins | 1 | 2014 | 62 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2019 | 1849 | 0.030 |
Why?
|
| Mass Screening | 2 | 2021 | 5252 | 0.030 |
Why?
|
| Genetic Privacy | 1 | 2014 | 60 | 0.030 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 1996 | 404 | 0.030 |
Why?
|
| Amino Acid Sequence | 4 | 2020 | 13817 | 0.030 |
Why?
|
| Referral and Consultation | 2 | 2017 | 3528 | 0.030 |
Why?
|
| Connective Tissue Diseases | 1 | 2016 | 264 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2020 | 3846 | 0.030 |
Why?
|
| Myopathies, Structural, Congenital | 1 | 2014 | 102 | 0.030 |
Why?
|
| Educational Status | 1 | 2021 | 2539 | 0.030 |
Why?
|
| Lod Score | 1 | 2013 | 615 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2018 | 2297 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2019 | 1538 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2022 | 2969 | 0.030 |
Why?
|
| Viral Load | 1 | 2021 | 3300 | 0.030 |
Why?
|
| Models, Biological | 1 | 2009 | 9582 | 0.030 |
Why?
|
| Financing, Organized | 1 | 2014 | 202 | 0.030 |
Why?
|
| Europe | 1 | 2019 | 3339 | 0.030 |
Why?
|
| Heat-Shock Proteins | 1 | 1996 | 822 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2018 | 1147 | 0.030 |
Why?
|
| Ovarian Neoplasms | 2 | 2019 | 4837 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 2422 | 0.030 |
Why?
|
| Consanguinity | 1 | 2013 | 456 | 0.030 |
Why?
|
| Decision Trees | 1 | 2013 | 506 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2018 | 3923 | 0.030 |
Why?
|
| Autophagy | 1 | 2019 | 1300 | 0.030 |
Why?
|
| Electronic Mail | 1 | 2013 | 213 | 0.030 |
Why?
|
| Acute Disease | 1 | 2022 | 7148 | 0.020 |
Why?
|
| Codon | 1 | 2013 | 611 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2022 | 1973 | 0.020 |
Why?
|
| Elapid Venoms | 1 | 1991 | 40 | 0.020 |
Why?
|
| Inservice Training | 1 | 2014 | 392 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 1997 | 2422 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2013 | 655 | 0.020 |
Why?
|
| Petrous Bone | 1 | 2011 | 86 | 0.020 |
Why?
|
| RNA Interference | 1 | 2019 | 2890 | 0.020 |
Why?
|
| Prognosis | 3 | 2018 | 29050 | 0.020 |
Why?
|
| Dark Adaptation | 1 | 2011 | 219 | 0.020 |
Why?
|
| Cardiomyopathy, Hypertrophic, Familial | 1 | 2010 | 66 | 0.020 |
Why?
|
| Reimbursement Mechanisms | 1 | 2016 | 670 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 2019 | 1702 | 0.020 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2017 | 780 | 0.020 |
Why?
|
| Peptides | 1 | 1982 | 4407 | 0.020 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2011 | 204 | 0.020 |
Why?
|
| Electroretinography | 1 | 2011 | 509 | 0.020 |
Why?
|
| Neurotoxins | 1 | 1991 | 237 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2022 | 2940 | 0.020 |
Why?
|
| Internationality | 1 | 2015 | 1003 | 0.020 |
Why?
|
| Escherichia coli Proteins | 1 | 1996 | 1053 | 0.020 |
Why?
|
| Cochlear Nerve | 1 | 2011 | 197 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 950 | 0.020 |
Why?
|
| Mitochondria | 1 | 2022 | 3520 | 0.020 |
Why?
|
| Filtration | 1 | 2009 | 234 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2013 | 13096 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2015 | 1426 | 0.020 |
Why?
|
| Education, Medical, Continuing | 1 | 2014 | 840 | 0.020 |
Why?
|
| Physicians, Primary Care | 1 | 2015 | 591 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 4477 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 9735 | 0.020 |
Why?
|
| Protein Binding | 1 | 2020 | 9392 | 0.020 |
Why?
|
| Health Services Research | 1 | 2016 | 1836 | 0.020 |
Why?
|
| Potassium Channels | 1 | 1991 | 563 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2021 | 6196 | 0.020 |
Why?
|
| Reference Standards | 1 | 2011 | 1025 | 0.020 |
Why?
|
| Tomography, Optical Coherence | 2 | 2011 | 2657 | 0.020 |
Why?
|
| Point-of-Care Systems | 1 | 2016 | 1176 | 0.020 |
Why?
|
| Blood Platelets | 1 | 2018 | 2508 | 0.020 |
Why?
|
| Synaptic Vesicles | 1 | 1988 | 191 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2012 | 1962 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2013 | 2649 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 2012 | 996 | 0.020 |
Why?
|
| Heart Defects, Congenital | 2 | 2014 | 4586 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 3086 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2011 | 2256 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2017 | 2616 | 0.020 |
Why?
|
| Cardiology | 1 | 2018 | 1668 | 0.020 |
Why?
|
| Publishing | 1 | 2014 | 833 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 2016 | 13990 | 0.020 |
Why?
|
| Cell Movement | 1 | 2018 | 5216 | 0.020 |
Why?
|
| Patient Participation | 1 | 2015 | 1457 | 0.020 |
Why?
|
| Vertigo | 1 | 2007 | 202 | 0.020 |
Why?
|
| Registries | 1 | 2021 | 8090 | 0.020 |
Why?
|
| Health Behavior | 1 | 2017 | 2636 | 0.020 |
Why?
|
| Rana catesbeiana | 1 | 2004 | 86 | 0.020 |
Why?
|
| Health Personnel | 1 | 2018 | 3216 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2016 | 1797 | 0.020 |
Why?
|
| Decision Making | 1 | 2018 | 3888 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2011 | 2374 | 0.020 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 2208 | 0.010 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2004 | 134 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2017 | 3023 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2002 | 18027 | 0.010 |
Why?
|
| Neurons | 1 | 1982 | 9335 | 0.010 |
Why?
|
| Bungarotoxins | 1 | 1982 | 46 | 0.010 |
Why?
|
| Synaptic Membranes | 1 | 1982 | 91 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 21824 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 1996 | 3849 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2018 | 19227 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2015 | 9849 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1987 | 4321 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 2004 | 572 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2016 | 20123 | 0.010 |
Why?
|
| Curriculum | 1 | 2014 | 3604 | 0.010 |
Why?
|
| Chick Embryo | 1 | 1982 | 982 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 2014 | 3227 | 0.010 |
Why?
|
| Chickens | 1 | 1982 | 865 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2004 | 1950 | 0.010 |
Why?
|
| Ear, Inner | 1 | 2004 | 420 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2004 | 1099 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 7908 | 0.010 |
Why?
|
| Molecular Weight | 2 | 1996 | 2255 | 0.010 |
Why?
|
| Incidence | 1 | 2018 | 20945 | 0.010 |
Why?
|
| Visual Acuity | 1 | 2008 | 2530 | 0.010 |
Why?
|
| Glycoproteins | 1 | 1987 | 2263 | 0.010 |
Why?
|
| Quantitative Trait Loci | 1 | 2007 | 2019 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2004 | 2726 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2014 | 4687 | 0.010 |
Why?
|
| Synaptophysin | 2 | 1988 | 141 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 35423 | 0.010 |
Why?
|
| Spheroplasts | 1 | 1996 | 6 | 0.010 |
Why?
|
| Laminin | 1 | 1998 | 419 | 0.010 |
Why?
|
| Frameshift Mutation | 1 | 1998 | 399 | 0.010 |
Why?
|
| Antibodies | 1 | 2004 | 2461 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1996 | 279 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1998 | 658 | 0.010 |
Why?
|
| Teaching | 1 | 2003 | 1174 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 1998 | 709 | 0.010 |
Why?
|
| Linear Models | 1 | 2005 | 5953 | 0.010 |
Why?
|
| Glycosylation | 1 | 1998 | 1126 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 39045 | 0.010 |
Why?
|
| Fibronectins | 1 | 1998 | 725 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2005 | 2916 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2016 | 77426 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1987 | 7723 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2004 | 3617 | 0.010 |
Why?
|
| Zebrafish | 1 | 2004 | 2994 | 0.010 |
Why?
|
| Genes, Bacterial | 1 | 1996 | 1079 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 1998 | 1602 | 0.010 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2007 | 3658 | 0.010 |
Why?
|
| Time Factors | 1 | 2013 | 40063 | 0.010 |
Why?
|
| Antigens, Bacterial | 1 | 1996 | 1171 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1998 | 6313 | 0.010 |
Why?
|
| Hot Temperature | 1 | 1996 | 1355 | 0.010 |
Why?
|
| Epitopes | 1 | 1996 | 2571 | 0.010 |
Why?
|
| Proteolipids | 1 | 1988 | 117 | 0.010 |
Why?
|
| Kinetics | 1 | 1996 | 6474 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 15538 | 0.000 |
Why?
|
| Electrophysiology | 1 | 1991 | 1310 | 0.000 |
Why?
|
| Immunoblotting | 1 | 1991 | 1682 | 0.000 |
Why?
|
| Macromolecular Substances | 1 | 1988 | 1456 | 0.000 |
Why?
|
| Membrane Potentials | 1 | 1988 | 1137 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1988 | 2645 | 0.000 |
Why?
|
| Gene Expression | 1 | 1998 | 7799 | 0.000 |
Why?
|
| Cattle | 1 | 1991 | 3922 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1996 | 9275 | 0.000 |
Why?
|
| Rats | 1 | 1987 | 24273 | 0.000 |
Why?
|